Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Clinical Relevance of Indoleamine 2,3-Dioxygenase (Guest Editor: Dietmar Fuchs) ] promotion: free to download

Volume:8   Issue: 3
Pp: 195-195
Dietmar Fuchs
DOI: 10.2174/138920007780362563

Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells

Volume:8   Issue: 3
Pp: 209-216
Francesca Fallarino, S. Gizzi, P. Mosci, U. Grohmann and P. Puccetti
DOI: 10.2174/138920007780362581

How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation

Volume:8   Issue: 3
Pp: 217-223
Adriano Boasso and Gene M. Shearer
DOI: 10.2174/138920007780362527

Indoleamine-2, 3-Dioxygenase and Other Interferon-γ-Mediated Pathways in Patients with Human Immunodeficiency Virus Infection

Volume:8   Issue: 3
Pp: 225-236
Katharina Schroecksnadel, R. Zangerle, R. Bellmann-Weiler, K. Garimorth, G. Weiss and Dietmer Fuchs
DOI: 10.2174/138920007780362608

Indoleamine 2,3-Dioxygenase in Hematopoietic Stem Cell Transplantation

Volume:8   Issue: 3
Pp: 267-272
U. Hainz, B. Jurgens, T. Wekerle, M. G. Seidel and Andreas Heitger
DOI: 10.2174/138920007780362554

Implications of IFN-γ-Mediated Tryptophan Catabolism on Solid Organ Transplantation

Volume:8   Issue: 3
Pp: 273-282
Gerald Brandacher, Raimund Margreiter and Dietmer Fuchs
DOI: 10.2174/138920007780362536

IDO and Clinical Conditions Associated with Depressive Symptoms

Volume:8   Issue: 3
Pp: 283-287
Claudia Kohl and B. Sperner-Unterweger
DOI: 10.2174/138920007780362572

Chronic Immune Activation Underlies Morbid Obesity: Is IDO A Key Player?

Volume:8   Issue: 3
Pp: 289-295
G. Brandacher, E. Hoeller, D. Fuchs and Helmut G. Weiss
DOI: 10.2174/138920007780362590